Halle Hunt

Halle Hunt joined Oncotherapeutics in 2023. She gained valuable experience in the clinical research industry, notably as an Associate Clinical Trial Manager at Care Access. She played a pivotal role in managing clinical studies in multiple therapeutic areas, enhancing patient care standards, and optimizing operational procedures. Her responsibilities included coordinating activities among various departments, monitoring project status, and acting as the primary liaison between clients and the company.

Prior to this role, she served as a Clinical Operations Coordinator at Care Access, working on COVID-19 antibody trials during the global pandemic. In this dynamic role, she managed multiple projects remotely while traveling to different sites monitoring the study procedures and clinical staff.

Halle completed her Master of Science in Healthcare Administration from Oklahoma State University in December 2020. Her coursework included in-depth studies in Research Design, Health Informatics, Healthcare Accounting and Auditing, and Leadership Methods in Healthcare. During her journey, she conducted a comprehensive dissertation on the disease analysis of Ebola, showcasing her research prowess and dedication to understanding critical healthcare issues.

Halle also pursued a Bachelor of Science in Public Health from the University of North Carolina At Wilmington. She was a Division 1 athlete and actively engaged with research in her academic life, submitting a study proposal to the Institutional Review Board (IRB) and conducting the study within her college athlete community.